Trial Profile
Granulocyte-Colony Stimulating Factor In Ischemic Stroke (GIST): A Pilot Study.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- Acronyms GIST
- 06 Feb 2013 Results presented at the 38th International Stroke Conference.
- 12 Jul 2012 Planned end date changed from 1 Dec 2011 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 12 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.